HPV DNA Test
Human Papillomavirus, HPV, HPV DNA, high risk, genotype 16, genotype 18, cervical cancer screening, ASCUS, co-testing , EPIC: LAB6847, SOFT: HPVO
Specimen Collection Criteria
ThinPrep® PreservCyt® vial: Cervical Swab or brush.
Physician Office/Drawsite Specimen Preparation
Maintain specimens in PreservCyt® solution, refrigerated (2-8°C or 36-46°F) or at room temperature (20-26°C or 68-78.8°F).
Preparation for Courier Transport
Transport: PreservCyt® vial, at room temperature (20-26°C or 68-78.8°F) or refrigerated (2-8°C or 36-46°F).
- Unlabeled specimens.
- Specimens received in Qiagen/Digene collection kits or specimen transport medium systems.
Monday - Friday.
Results available within 1-3 business days.
Nucleic Acid Amplification (FDA Approved). Roche Cobas® HPV Test.
Qualitative detection of fourteen high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) associated with the development or progression of invasive cervical carcinoma. This test provides genotype-specific reporting at no additional cost as follows: HPV genotype 16, HPV genotype 18 and Other HPV High Risk.
This test includes an internal control (human β-globin) to ensure adequate specimen cellularity. Samples lacking detectable internal control will be reported inadequate. A negative result does not exclude the possibility of HPV infection. Very low levels of infection may cause a false-negative result. Bloody specimens may give false-negative results.
This test aids in the detection of high risk HPV infection associated with the development or progression of invasive cervical carcinoma. It serves as an adjunct to the Pap smear in the identification of women who may be at increased risk for cervical intraepithelial neoplasia. Genotype-specific reporting of HPV types 16 and 18 also aid in the appropriate management of patients who may need referral to coloscopy.
EPIC: LAB6847, SOFT: HPVO